Home > NewsRelease > COVID-19 quick takes--part one
Text
COVID-19 quick takes--part one
From:
Michael D. Shaw -- Expert in Health Care and Environmental Affairs Michael D. Shaw -- Expert in Health Care and Environmental Affairs
For Immediate Release:
Dateline: Washington, DC
Sunday, November 15, 2020

 

Quick_takes

This HND piece presents several new findings on COVID-19, including the retraction of a big mask study; the Pfizer/BioNTech Vaccine; the Vitamin D connection; and melatonin as a possible therapy. While the authorities seem to be trying to scare us about the pandemic again, they are doubling down on lockdowns and masks.

But, here's the thing: For the most part, people have been compliant with these policies, yet infection rates continue to rise. Maybe, though, there's something wrong with the testing. Both Elon Musk and Erykah Badu have recently announced laughably inconsistent results for their COVID testing.

Under normal circumstances, we should be patient, and only post links to perfect studies, but the sad fact is, that there is almost no actual science being done these days. As such, we can only evaluate items of interest, and make them available to you.

Read the complete article.

Interscan Corporation
4590 Ish Drive
Simi Valley, CA 93063-7682

Phone:    1 800 458-6153 (US and Canada)
               (818) 882-2331
Web:      www.halimeter.com
Interscan Twitter

News Media Interview Contact
Name: Michael D. Shaw
Title: Executive VP/Director of Marketing
Group: Interscan Corporation
Dateline: Reston, VA United States
Direct Phone: 703-796-6063
Main Phone: 1 800 458-6153
Cell Phone: 818-481-0626
Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs
Contact Click to Contact